Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-the role of the GLP-1 receptor
This is particularly important now that artemisinin partial resistance is emerging in Africa
BPC-157 5mg Summary Description: BPC-157 is a synthetic pentadecapeptide corresponding to a partial sequence of a protein found in human gastric juice
Lixisenatide Monotherapy GetGoal-Mono was a 12-week, double-blind, placebo-controlled trial that randomised 361 patients with type 2 diabetes of mean duration 1.11.4 years attempting to control their diabetes with diet and exercise alone, to lixisenatide OD for 12 weeks as a one-step dose increase (10 g for 2 weeks, then 20 g) or two-step dose increase (10 g for 1 week, 15 g for 1 week, then 20 g), or placebo also with a one- or two-step increase [17]
